Abstract

SC11.03 ROS1 as a Therapeutic Target in Advanced NSCLC

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Targeting ROS1 Rearrangements in Non-small Cell Lung Cancer: Crizotinib and Newer Generation Tyrosine Kinase Inhibitors.
Tessa A Morris ... Christine Khoo
Drugs | VOL. 79
Tessa A Morris, et. al.Tessa A Morris ... Christine Khoo
16 Jul 2019
Validating ROS1 rearrangements as a therapeutic target in non-small-cell lung cancer.
Benjamin Solomon
Journal of Clinical Oncology | VOL. 33
Benjamin SolomonBenjamin Solomon
09 Feb 2015
Cabozantinib overcomes crizotinib resistance in ROS1 fusion-positive cancer.
Ryohei Katayama ... Elizabeth L Lockerman
Clinical cancer research : an official journal of the American Association for Cancer Research | VOL. 21
Ryohei Katayama, et. al.Ryohei Katayama ... Elizabeth L Lockerman
01 Jan 2015
Abstract C084: Crizotinib resistance mechanisms and potential therapeutic strategies to overcome the resistance in ROS1-rearranged non-small cell lung cancer
Ryohei Katayama ... Naoya Fujita
Molecular Cancer Therapeutics | VOL. 18
Ryohei Katayama, et. al.Ryohei Katayama ... Naoya Fujita
01 Dec 2019
View more papers

More From: Journal of Thoracic Oncology

Paper Title
Journal
Date
Author
Analysis of Circulating Tumor DNA Predicts Outcomes of Short-Course Consolidation Immunotherapy in Unresectable Stage III NSCLC
Soyeong Jun ... Maximilian Diehn
Journal of Thoracic Oncology | VOL. -
Soyeong Jun, et. al.Soyeong Jun ... Maximilian Diehn
05 Jul 2024
PP01.95 STK11, KEAP1, and KRAS mutation epidemiology and real-world outcomes in US patients with newly diagnosed metastatic non-small cell lung cancer
Firas Dabbous ... Ferdinandos Skoulidis
Journal of Thoracic Oncology | VOL. 19
Firas Dabbous, et. al.Firas Dabbous ... Ferdinandos Skoulidis
01 Jul 2024
PP01.11 Real-world treatment patterns and outcomes among unresectable Stage III Non-Small Cell Lung Cancer
Ashwini Arunachalam ... Jerome Goldschmidt
Journal of Thoracic Oncology | VOL. 19
Ashwini Arunachalam, et. al.Ashwini Arunachalam ... Jerome Goldschmidt
01 Jul 2024
PP01.133 Clinical and Economic Outcomes Associated with Genomic Testing Strategies in Real-World Data in Advanced Non-Small Cell Lung Cancer (aNSCLC)
Benjamin Levy ... Teddy Saliba
Journal of Thoracic Oncology | VOL. 19
Benjamin Levy, et. al.Benjamin Levy ... Teddy Saliba
01 Jul 2024
View more papers